Work

A Predictive Model for COPD Exacerbations Using ProAir Digihaler: A 12-Week, Open-Label Study

Year: 2020

Type: conference-abstract

Source: American Journal of Respiratory and Critical Care Medicine

DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4485

Authors: L.D. Snyder, G. Safioti, M. Reich, M. Neely, N. Lugogo, R.A. Pleasants, T. Li, L. Granovsky, M. DePietro

Institutions: Duke Medical Center, Teva Pharmaceuticals (Netherlands), Teva Pharmaceuticals (Israel), University of Michigan, University of North Carolina at Chapel Hill, Teva Pharmaceuticals (United States)

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3041733332

Cites:

Cited by: 6

Related to: 10